Stem cells combined with islet transplant for diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and your pancreas makes very little or no insulin.
- Your average blood sugar (HbA1c) is 7% or higher.
- You have frequent or severe low blood sugar episodes despite insulin therapy.
- You are between 18 and 70 years old.
- You do not have active infections, serious heart or kidney disease, or a history of certain cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This trial tests whether transplanting insulin-producing “islet” cells can better control blood sugar in people who have already received a kidney transplant. It’s mainly for adults with type 1 diabetes whose body is no longer making enough insulin, while they are on kidney-transplant medicines.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.